[Respiratory complications of drugs used in neurology and psychiatry].
D000927:Anticonvulsants / Q000009:adverse effects; D000978:Antiparkinson Agents / Q000009:adverse effects; D001337:Autonomic Agents / Q000009:adverse effects*; D001971:Bromocriptine / Q000009:adverse effects; D002492:Central Nervous System Depressants / Q000009:adverse effects*; D004876:Ergot Alkaloids / Q000009:adverse effects; D005260:Female; D006801:Humans; D008171:Lung Diseases / Q000139:chemically induced*; D008297:Male; D008784:Methysergide / Q000009:adverse effects; D008875:Middle Aged; D011619:Psychotropic Drugs / Q000009:adverse effects*; D011658:Pulmonary Fibrosis / Q000139:chemically induced
D000927:Anticonvulsants; D000978:Antiparkinson Agents; D001337:Autonomic Agents; D002492:Central Nervous System Depressants; D004876:Ergot Alkaloids; D011619:Psychotropic Drugs; D001971:Bromocriptine; D008784:Methysergide
Complications respiratoires des médicaments utilisés en neurologie et en psychiatrie.